HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The levels of quinone reductases, superoxide dismutase and glutathione-related enzymatic activities in diethylstilbestrol-induced carcinogenesis in the kidney of male Syrian golden hamsters.

Abstract
The level of quinone oxidoreductases (microsomal and cytosolic DT-diaphorase, NADPH-cytochrome P450 reductase and NADH-cytochrome b5 reductase), superoxide dismutase and glutathione-related enzymatic activities in diethylstilbestrol (DES)-induced carcinogenesis in kidney from Syrian golden hamsters are presented. Animals that exhibited two different stages of DES-induced carcinogenesis in kidney--pre- and neoplastic lesions and tumorous lesions (after 6 and 8 months of continuous exposure to DES respectively)--were studied in comparison to kidneys from control animals. A dramatic decrease in microsomal and cytosolic DT-diaphorase activities (13.6 and 37.8% of controls), as well as in glutathione disulphide reductase (39.5%), and less marked in superoxide dismutase (45.6%), NADH cytochrome b5 reductase (61.9%) glutathione transferase (GST) towards 1-chloro-2,4-dinitrobenzene (CDNB) (66.2%) and glutathione peroxidase (GSH-Px) (80%) activities, were observed in kidneys with pre- and neoplastic lesions. NADPH-cytochrome P450 reductase and GST activity towards 4-hydroxy-2,3-trans-nonenal (4-HNE) showed no statistically significant variation at this stage of carcinogenesis. In kidney from animals with tumorous lesions, all the enzymatic activities mentioned above decreased, except for superoxide dismutase, which was increased to 186% of the control activity. GST activity towards 4-HNE again showed no statistically significant variation. These results suggest that if one-electron reduction of diethylstilbestrol-4',4''-quinone (DESQ) occurs, it may play a very important role in the development of DES carcinogenesis (pre- and neoplastic lesions), since at this stage of carcinogenesis the primary defense mechanisms against the oxygen free radicals generated in this way, i.e. SOD activity, is reduced to less than a half of control values. Both cytosolic and microsomal DT-diaphorase activities are unable at this stage of carcinogenesis to promote effectively the two-electron reduction of DESQ, which would avoid the initial formation of superoxide anion. The consequences of these decreases may be an increased steady-state concentration of superoxide anion and hydrogen peroxide, which in the presence of iron might lead to lipid peroxidation. GST activity towards 4-HNE could be responsible for the possible higher steady-state concentration of this lipid peroxidation product during DES treatment. The induction of DT-diaphorase and its protective role in the prevention of the development of pre- and neoplastic lesions in kidney from Syrian golden hamster during DES treatment is also discussed.
AuthorsJ Segura-Aguilar, V Cortés-Vizcaino, A Llombart-Bosch, L Ernster, E Monsalve, F J Romero
JournalCarcinogenesis (Carcinogenesis) Vol. 11 Issue 10 Pg. 1727-32 (Oct 1990) ISSN: 0143-3334 [Print] England
PMID2119905 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Diethylstilbestrol
  • Cytochromes b5
  • Glutathione Peroxidase
  • Superoxide Dismutase
  • NADPH-Ferrihemoprotein Reductase
  • Quinone Reductases
  • Glutathione Transferase
Topics
  • Animals
  • Cricetinae
  • Cytochromes b5 (metabolism)
  • Cytosol (enzymology)
  • Diethylstilbestrol (toxicity)
  • Glutathione Peroxidase (metabolism)
  • Glutathione Transferase (metabolism)
  • Kidney (drug effects, enzymology, pathology)
  • Kidney Neoplasms (chemically induced, enzymology, pathology)
  • Male
  • Mesocricetus
  • Microsomes (enzymology)
  • NADPH-Ferrihemoprotein Reductase (metabolism)
  • Precancerous Conditions (enzymology, pathology)
  • Quinone Reductases (metabolism)
  • Reference Values
  • Superoxide Dismutase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: